Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 22151-22200 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT06929910
Assessing Systemic Treatment and ctDNA Monitoring Efficacy in Metastatic Cancer Patients Using K4Care Testing.
N/A
Recruiting
200 participants
Started: Apr 9, 2025 · Completed: Jun 30, 2027
1 condition
2 sponsors
1 location
NCT06836947
The Effect of Two Different Bathing Methods on Vital Signs and Comfort in PICU:Bath Trial
N/A
Recruiting
52 participants
Started: Apr 9, 2025 · Completed: May 30, 2025
2 conditions
1 sponsor
1 location
NCT06904105
A Trial of HRS-7535 Tablets in Subjects With Overweight or Obesity
PHASE3
Active, not recruiting
556 participants
Started: Apr 9, 2025 · Completed: May 31, 2026
2 conditions
1 sponsor
1 location
NCT06679374
Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease
PHASE2
Recruiting
102 participants
Started: Apr 9, 2025 · Completed: Jan 31, 2027
1 condition
2 sponsors
1 location
NCT06629766
The EPIC Study: Exploring Paternal Age and the Influence on Blastocyst Culture
NA
Recruiting
100 participants
Started: Apr 9, 2025 · Completed: Dec 31, 2026
5 conditions
1 sponsor
1 location
NCT06930599
Circumferential Pulmonary Vein Isolation Plus Transition Zone Modification in Atrial Fibrillation Patients Without Low-Voltage Areas
NA
Not yet recruiting
162 participants
Started: Apr 9, 2025 · Completed: Oct 9, 2026
1 condition
1 sponsor
0 locations
NCT06762002
Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort
N/A
Recruiting
500 participants
Started: Apr 9, 2025 · Completed: Jan 31, 2029
4 conditions
1 sponsor
9 locations
NCT06731270
Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent Immunotherapy
PHASE2
Recruiting
20 participants
Started: Apr 9, 2025 · Completed: Jan 1, 2027
4 conditions
2 sponsors
2 locations
NCT06580106
Toxicity Genetic Determinants and Response to Azacitidine and Venetoclax in AML
N/A
Recruiting
50 participants
Started: Apr 9, 2025 · Completed: Jan 31, 2030
1 condition
3 sponsors
2 locations
NCT06907784
PRE-EMPTIVE PHARMACOGENOMICS IN ACUTE CARE SETTINGS WITH HEALTH ECONOMIC EVALUATIONS (PHOENIX TRIAL)
NA
Recruiting
2,000 participants
Started: Apr 9, 2025 · Completed: Sep 30, 2026
1 condition
2 sponsors
1 location
NCT06656702
Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis
EARLY_PHASE1
Recruiting
24 participants
Started: Apr 9, 2025 · Completed: Jul 1, 2026
1 condition
2 sponsors
1 location
NCT06860828
The DIAGNOSE CTE Research Project-II
N/A
Enrolling by invitation
350 participants
Started: Apr 9, 2025 · Completed: Jul 31, 2029
4 conditions
8 sponsors
5 locations
NCT06694272
Functional and Anatomical Visual Investigations in Patients With Early Forms of Age-related Macular Degeneration
N/A
Recruiting
120 participants
Started: Apr 9, 2025 · Completed: Apr 30, 2031
1 condition
1 sponsor
1 location
NCT07016932
Menstrual Management Using a Mobile Application in Adolescent Girls With Mild Intellectual Disabilities
NA
Enrolling by invitation
82 participants
Started: Apr 9, 2025 · Completed: Jan 30, 2026
4 conditions
1 sponsor
1 location
NCT07209306
WHO Psychological Interventions for Mental Health Outcomes in Migrants Resettled in Italy: the ADVANCE Trial
NA
Recruiting
237 participants
Started: Apr 9, 2025 · Completed: Apr 30, 2027
2 conditions
2 sponsors
1 location
NCT06556654
Tissue Reinforcement for Breast Reconstruction (TRBR) Pivotal Clinical Study (REDEFINE)
NA
Recruiting
180 participants
Started: Apr 9, 2025 · Completed: Jul 31, 2030
1 condition
2 sponsors
20 locations
NCT06904053
Metagenomics Next-generation Sequencing Approach to Detect Microbial DNA/RNA Overtime in Individuals Undergoing Hematopoietic Stem Cell Transplant
N/A
Recruiting
30 participants
Started: Apr 9, 2025 · Completed: Dec 30, 2030
1 condition
1 sponsor
1 location
NCT06866275
Suramin for the Treatment of Autism Trial: KZ101 in a Male Pediatric Population With Autism Spectrum Disorder (ASD)
PHASE2
Recruiting
45 participants
Started: Apr 9, 2025 · Completed: Apr 30, 2028
1 condition
2 sponsors
1 location
NCT07119944
Pose Estimation and Inertial Measurement Unit Systems for Gait Analysis in Older Adults
N/A
Active, not recruiting
30 participants
Started: Apr 9, 2025 · Completed: Jul 9, 2026
1 condition
2 sponsors
1 location
NCT06858969
Chidamide in Combination With PD-1 Inhibitor, Bevacizumab, and XELOX for Metastatic Colorectal Cancer
PHASE2
Not yet recruiting
130 participants
Started: Apr 9, 2025 · Completed: Jan 8, 2028
1 condition
1 sponsor
0 locations
NCT06472622
Functional Neuroimaging to Detect the Neural Signatures of the Unpleasantness of Pain and Effort
EARLY_PHASE1
Recruiting
47 participants
Started: Apr 9, 2025 · Completed: Jun 30, 2034
1 condition
1 sponsor
1 location
NCT06835530
A Combination of Rituximab and CC-99282 as Front-line Therapy for Older Frail Patients With Diffuse Large B-cells Non-Hodgkin Lymphoma Evaluated With a Simplified Geriatric Assessment (sGA): a Phase II Study of the Fondazione Italiana Linfomi (FIL)
PHASE2
Recruiting
47 participants
Started: Apr 9, 2025 · Completed: Apr 30, 2030
1 condition
1 sponsor
19 locations
NCT06952413
Study of the Efficacy and Safety for Rituximab in Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
PHASE2
Recruiting
30 participants
Started: Apr 9, 2025 · Completed: Oct 31, 2027
1 condition
1 sponsor
1 location
NCT06793475
Aponermin-Based Bridging Therapy Prior to CAR-T Infusion in Relapsed/Refractory Multiple Myeloma Patients With Extramedullary Disease
NA
Recruiting
20 participants
Started: Apr 9, 2025 · Completed: Dec 31, 2026
1 condition
1 sponsor
2 locations
NCT06916637
Clinical Study on the Application of 18F-HER2 Affibody PET Imaging in HER2-Expressing Breast Cancer
N/A
Recruiting
40 participants
Started: Apr 9, 2025 · Completed: Dec 31, 2027
2 conditions
1 sponsor
1 location
NCT06726096
Phase III Trial of VDJ001 In Patients With Moderate-to-severe Active Rheumatoid Arthritis
PHASE3
Enrolling by invitation
615 participants
Started: Apr 9, 2025 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT06247904
NIBS Therapy in Subacute Spinal Cord Injury
NA
Enrolling by invitation
20 participants
Started: Apr 9, 2025 · Completed: May 31, 2026
2 conditions
7 sponsors
1 location
NCT05066217
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
PHASE3
Recruiting
260 participants
Started: Apr 9, 2025 · Completed: Nov 1, 2029
1 condition
2 sponsors
4 locations
NCT07012642
Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema
EARLY_PHASE1
Recruiting
110 participants
Started: Apr 9, 2025 · Completed: Apr 9, 2027
1 condition
1 sponsor
2 locations
NCT06805331
The Effect of Health Belief Model-Based Pelvic Floor Muscle Exercise Training on Urinary Incontinence and Quality of Life in Female Patients With Multiple Sclerosis
NA
Not yet recruiting
46 participants
Started: Apr 9, 2025 · Completed: Jun 13, 2025
2 conditions
1 sponsor
1 location
NCT06604104
Visual Frailty in Ageing
N/A
Recruiting
20 participants
Started: Apr 9, 2025 · Completed: Feb 28, 2026
8 conditions
2 sponsors
2 locations
NCT06911320
Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepatic Function
PHASE1
Recruiting
28 participants
Started: Apr 9, 2025 · Completed: Nov 30, 2025
3 conditions
1 sponsor
2 locations
NCT06497959
Study of Placental Vascularization Using Contrast Ultrasound
PHASE3
Recruiting
30 participants
Started: Apr 9, 2025 · Completed: Apr 10, 2029
1 condition
1 sponsor
1 location
NCT06956716
Personalized Tumor Neoantigen mRNA Therapy for Advanced Intrahepatic Cholangiocarcinoma
PHASE1/PHASE2
Recruiting
30 participants
Started: Apr 9, 2025 · Completed: Apr 1, 2028
1 condition
2 sponsors
1 location
NCT06838845
An Observational Study to Evaluate Effectiveness and Safety of Upadacitinib in Chinese Adult Participants With Moderate to Severely Active Ulcerative Colitis (UC)
N/A
Recruiting
80 participants
Started: Apr 9, 2025 · Completed: Mar 31, 2027
1 condition
1 sponsor
3 locations
NCT06917742
A Study of CPTX2309 in Healthy Participants
PHASE1
Recruiting
38 participants
Started: Apr 9, 2025 · Completed: Feb 28, 2026
1 condition
1 sponsor
1 location
NCT06824467
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
PHASE3
Recruiting
770 participants
Started: Apr 9, 2025 · Completed: Oct 15, 2032
3 conditions
3 sponsors
30 locations
NCT06603064
Neuromodulation of Brain and Emotional Responses to Psychological Stress
NA
Recruiting
55 participants
Started: Apr 9, 2025 · Completed: Jul 31, 2029
2 conditions
2 sponsors
1 location
NCT07055971
Pain Neuroscience Education, Conditioned Pain Modulation and Emotional Processes in Fibromyalgia
NA
Enrolling by invitation
46 participants
Started: Apr 9, 2025 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT06837103
Real-world Effects of Using Intermittently Scanned Continuous Glucose Monitoring and Pharmacist-led Coaching on the Management of Type 2 Diabetes Among Adults Not Using Insulin (REAL isCGM T2D)
N/A
Recruiting
250 participants
Started: Apr 9, 2025 · Completed: May 31, 2026
1 condition
2 sponsors
1 location
NCT06994494
Noninvasive Continuous BP Monitoring in Newborns Based on Pulsatile Signal Morphological Features Using NIRS
N/A
Recruiting
80 participants
Started: Apr 9, 2025 · Completed: Nov 30, 2026
2 conditions
2 sponsors
2 locations
NCT06920043
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
PHASE2
Recruiting
42 participants
Started: Apr 9, 2025 · Completed: Dec 31, 2027
1 condition
2 sponsors
35 locations
NCT06790693
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
PHASE3
Recruiting
450 participants
Started: Apr 9, 2025 · Completed: May 30, 2032
1 condition
1 sponsor
154 locations
NCT06920030
Performance of the Cardiac Microcurrent (C-MIC) System With a Less Invasively Placed Left Ventricular Lead
NA
Recruiting
33 participants
Started: Apr 9, 2025 · Completed: Jun 30, 2026
2 conditions
2 sponsors
2 locations
NCT06995105
Personalized Tumor Neoantigen mRNA Therapy for Advanced Hepatocellular Carcinoma
PHASE1/PHASE2
Recruiting
30 participants
Started: Apr 9, 2025 · Completed: Apr 1, 2028
1 condition
2 sponsors
1 location
NCT06943586
Pharmacogenomics in Stroke: Feasibility of CYP2C19 Testing
NA
Recruiting
200 participants
Started: Apr 9, 2025 · Completed: Apr 1, 2029
2 conditions
1 sponsor
1 location
NCT06831071
Evaluation of Hypoxia in Primary Melanoma
N/A
Recruiting
50 participants
Started: Apr 9, 2025 · Completed: Mar 31, 2027
1 condition
2 sponsors
1 location
NCT07123402
To Evaluate the Efficacy and Safety of TRD205 Tablets in the Treatment of Chronic Postoperative Neuralgia
PHASE2
Enrolling by invitation
184 participants
Started: Apr 9, 2025 · Completed: May 27, 2026
1 condition
2 sponsors
1 location
NCT06846554
"A Trial of APL-9796'' in Adults With Pulmonary Hypertension"
PHASE2
Recruiting
48 participants
Started: Apr 9, 2025 · Completed: Sep 30, 2027
1 condition
1 sponsor
1 location
NCT06926582
A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis
PHASE2
Not yet recruiting
305 participants
Started: Apr 9, 2025 · Completed: Dec 9, 2026
1 condition
1 sponsor
1 location
Previous
1
More pages
441
442
443
444
445
446
447
More pages
2369
Next